Tandem Diabetes Care, Inc. announced the appointment of Rebecca Robertson as Chair of its Board of Directors. Ms. Robertson, who joined Tandem's Board as an independent director in January 2019, succeeds Kim Blickenstaff, who will continue as a member of the Board. Ms. Robertson has an impressive track record of helping medical device companies scale in her roles as an engineer, entrepreneur, corporate executive and board member.

She is a founder and General Partner at Versant Ventures where she has specialized in investing in the areas of medical devices and diagnostics since 1999. In addition, through Longridge Business Advisors, she has provided business advisory services and board services since April 2017. Prior to Versant, she served as Senior Vice President at Chiron Diagnostics, where she had responsibility for the critical care business unit in addition to leading the division's business development efforts.

Prior to joining Chiron, Ms. Robertson was a co-founder and Vice President at Egis and held senior management positions in operations and finance at Lifescan. Ms. Robertson holds a BS in Chemical Engineering from Cornell University.